The School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin, in collaboration with the National Institute for Bioprocessing Research and Training (NIBRT), announced the upcoming Dr. Don Panoz Distinguished Lecture.
This year’s lecture, titled “CCRM and the Collaborative and Capital-Efficient Commercialization of Advanced Therapies: A New Take on the ‘Medium is the Message’,” will be delivered by Dr. Michael May, President and CEO of the Centre for Commercialization of Regenerative Medicine (CCRM), Canada.
Dr. May is a recognized leader in the field of regenerative medicine. As the head of CCRM, he has been instrumental in developing technologies, launching companies, and driving investment in cell and gene therapy. He co-founded Rimon Therapeutics Ltd. and serves on multiple boards and advisory committees across the biotechnology sector.
Event Details:
- Speaker: Dr. Michael May, President and CEO of CCRM
- Title: “CCRM and the Collaborative and Capital-Efficient Commercialization of Advanced Therapies: A New Take on the ‘Medium is the Message’”
- Date: 22 October
- Venue: Trinity College
